News

This webinar, hosted by BORN Ontario in partnership with the Canadian Obstetric Survey System (CanOSS) provides an overview of the pilot initiative for Ontario birthing facilities to collect data on severe peripartum hemorrhage events and participate in confidential reviews through the BORN Information System.

This webinar provides an overview of Prenatal Screening Ontario (PSO), including the prenatal screening it currently oversees and how performance is monitored across the province. It also highlights key resources for pregnant individuals and health‑care providers, including the PSO website and My Screening Pathway.

Join an upcoming webinar to learn more about CanOSS Ontario, its vision for reducing maternal morbidity and mortality, and opportunities for Ontario birthing facilities to participate as pilot sites for severe peripartum hemorrhage data collection and confidential reviews within the BORN Information System.

BORN is hosting an upcoming webinar that will provide an overview of the vision for BORNConnect and the dOPR+, highlight the opportunities these innovations present for patients and providers, and outline how a collaborative co-design approach will help shape a solution that is practical, interoperable, sustainable, safe, and secure.

BORNConnect is helping shape the future of pregnancy and newborn care in Ontario through the development of the Digital Ontario Perinatal Record Plus (DOPR+).

Hospitals across Ontario are reporting an increase in families declining the recommended intramuscular (IM) Vitamin K injection at birth. While this decision may be perceived as low risk, refusal increases the risk of Vitamin K Deficiency Bleeding (VKDB)—a rare but potentially serious and preventable condition in newborns.

At Minofest 2026, BORN Executive Director Alicia St. Hill delivered the keynote address, Data That Serves: A Shared Path to Equity Through SD/SDH Data and Responsible Governance. Drawing on BORN’s work to improve maternal and perinatal health outcomes, Alicia explored the critical role of data governance, accountability, and action in advancing health equity for racialized communities.

Prenatal screening can help identify risks like preterm preeclampsia early in pregnancy. Screening between 11 and 14 weeks, along with steps like low-dose aspirin when recommended, can help reduce risks and support safer outcomes for both parent and baby. Talk to your healthcare provider about getting screened.

Race is collected during preeclampsia screening to help make risk estimates more accurate, but it is not a cause of the condition. Social, structural, and genetic factors contribute to risk differences. Providing your race is voluntary, and all information is protected under Ontario’s privacy laws. Screening can still be done without it, though results may be less precise.

If your preeclampsia screening shows a higher risk, there are steps your healthcare provider can take to support you. These may include low-dose aspirin, closer monitoring, lifestyle guidance, and referral to a specialist when needed. Early screening and follow-up care help protect both parent and baby.